Biomodics specializes in developing silicone with new and improved characteristics. This can be used in developing new medical catheters for health care to reduce hospital acquired infections such as CAUTI and CLABSI. Click here to read more about the company, our mission and team, and to find out where we are located.
New materials are needed for medical tubing
Silicone is the material of choice for many medical tubing applications like urinary catheters due to it's desirable properties such as chemical inertness and high flexibility. However a common issue with medical tubing is the formation of bacterial biofilm inside and outside the tube often leading to infection. Biomodics' patented IPN technology makes the development of new medical tubing devices resistant to biofilm formation possible. Click here to read more about IPN
Hospital Acquired Infections cause unnecesary suffering
The first Foley catheter to prevent biofilm and stop CAUTI
Biomodics is currently developing a new IPN Foley urinary cathteter to help prevent catheter associated urinary tract infections (CAUTI) by eliminating biofilm formation. 15-25% of all hospitalized patients will have an indwelling urinary catheter placed. It is no surprise then that CAUTI remains the most common hospital infection. While CAUTI can be often be treated with antibiotics it does lead to an increased length of stay. Sometimes the urinary infection may even cause a potentially fatal blood stream infection. Biomodics is currently doing pre-clinical testing of a new IPN Foley catheter. In-vitro studies have shown that this effectively inhibits biofilm formation. We strongly believe this will lead to drastic reductions in the number of patients getting a urinary tract infection. After clinical testing we plan to be able to bring the new catheter to market in 2020.
Specialists in supercritical CO2 sterlization, extraction, and purification
Biomodics has developed unique competencies and knowledge about supercritical CO2 technology. Supercritical CO2 technology has many advantages and applications. It is currently being used in pharmaceutical and cosmetics industry, in the food sector, as well as in polymer technology. It provides an alternative way of extraction and purification without the use of organic solvents. That means there will be no organic residues. It can also be used working with nano particles and polymers. Supercritical CO2 technology also provides a gentler alternative to traditional sterilization methods. Biomodics is participating in a number of research partnerships utilizing scCO2.